News by topic

Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Bone and joint problems news

Show

From To
Ageing and HIV
Management of age-related conditions is 'the future of HIV care', says IAS conference keynote speaker

Other diseases are becoming far more important than AIDS for people with HIV who have consistent access and good response to antiretroviral treatment, and management of age-related comorbidities

Published
01 July 2013
By
Liz Highleyman
Bone and joint problems
Bone loss and fracture risk are 'modest' among HIV+ people, linked to tenofovir, smoking, and HCV

Continued bone loss among HIV positive men with osteopenia was modest overall, but about 25% of those taking tenofovir (Viread, also in 4 antiretroviral coformulations) experienced significant loss, according to a recent study. A related meta-analysis found that HIV infection is associated with a modest likelihood of new fractures, with smoking and hepatitis C virus (HCV) coinfection further increasing the risk.

Published
07 June 2013
From
HIVandHepatitis.com
New and experimental HIV treatments
New pro-drug tenofovir alafenamide appears equally effective but better tolerated

Tenofovir alafenamide fumarate or TAF (formerly GS-7340), a new pro-drug of the widely used NRTI tenofovir, reaches cells harbouring HIV more easily than the older tenofovir disoproxil

Published
07 March 2013
By
Liz Highleyman
Bone and joint problems
Frailty increases the risk of fragility fractures in men living with HIV: data collected in routine HIV care can help predict risk

Important physiologic markers of frailty are associated with fragility fractures in men living with HIV, according to research conducted in the United States and published in the

Published
18 February 2013
By
Michael Carter
Bone and joint problems
Co-infection with hepatitis B or C is a risk factor for reduced bone mineral density among women with HIV

Co-infection with hepatitis B or C is associated with reduced bone mineral density (BMD) in women living with HIV, French investigators report in the online edition of

Published
28 January 2013
By
Michael Carter
Child developmental issues
Bone mineral density below normal in children infected early with HIV

Bone mineral density was below the general population norm in US children perinatally infected with HIV and lower than in children perinatally exposed to HIV but uninfected.

Published
21 January 2013
From
International AIDS Society
Bone and joint problems
HIV treatment interruption associated with reduced bone loss in SMART trial

People who stopped antiretroviral therapy in the SMART trial had less bone loss and lower levels of bone metabolism biomarkers than people who remained on continuous antiretroviral therapy (ART), according to a report in the January 8, 2013, advance edition of Journal of Bone Mineral Research.

Published
16 January 2013
From
HIVandHepatitis.com
Ageing and HIV
Activist discusses challenge of growing old with HIV

Old age comes faster and hits harder for those infected with HIV, a fact aging health activist Ron Swanda knows all too well.

Published
30 November 2012
From
AFP
Bone and joint problems
Dutch find low bone mineral density in gay men, regardless of HIV infection status

The prevalence of low bone mineral density (BMD) is similar in HIV-positive and HIV-negative gay men, according to the results of Dutch research published in the online

Published
26 November 2012
By
Michael Carter
Bone and joint problems
Weekly alendronate improves bone density in adults taking ART

Alendronate significantly improved bone mineral density through 96 weeks of treatment in a double-blind placebo-controlled trial that enrolled adults with osteoporosis while taking antiretroviral therapy (ART).

Published
30 August 2012
From
International AIDS Society
← Prev1...56789...13Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.